COLL - COLLEGIUM PHARMACEUTICAL, INC
IEX Last Trade
29.09
0.130 0.447%
Share volume: 4,138
Last Updated: Fri 27 Dec 2024 06:29:52 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.94%
PREVIOUS CLOSE
CHG
CHG%
$28.96
0.13
0.45%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-07 | 2024-02-22 | 2024-05-09 | |
| Total revenue | 123.549 M | 127.013 M | 129.620 M | 144.767 M | 135.546 M | 136.709 M | 149.745 M | 144.923 M | |
| Cost of revenue | 33.684 M | 30.622 M | 37.552 M | 29.899 M | 24.257 M | 20.081 M | 20.601 M | 18.950 M | |
| Gross profit | 89.865 M | 96.391 M | 92.068 M | 114.868 M | 111.289 M | 116.628 M | 129.144 M | 125.973 M | |
| 7.26% | -4.48% | 24.76% | -3.12% | 4.80% | 10.73% | -2.46% | |||
| Operating expenses | 41.254 M | 38.372 M | 38.032 M | 52.775 M | 38.193 M | 35.298 M | 32.942 M | 41.982 M | |
| Selling general and admin | 41.254 M | 38.372 M | 38.032 M | 52.775 M | 38.193 M | 35.298 M | 32.942 M | 41.982 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 112.439 M | 106.546 M | 117.863 M | 120.140 M | 99.913 M | 91.696 M | 88.057 M | 95.449 M | |
| -5.24% | 10.62% | 1.93% | -16.84% | -8.22% | -3.97% | 8.39% | |||
| Operating income | 11.110 M | 20.467 M | 11.757 M | 24.627 M | 35.633 M | 45.013 M | 61.688 M | 49.474 M | |
| Ebit | 11.110 M | 20.467 M | 11.757 M | 24.627 M | 35.633 M | 45.013 M | 61.688 M | 49.474 M | |
| Pretax income | -6.646 M | 1.432 M | -7.791 M | -17.557 M | 17.797 M | 28.783 M | 46.710 M | 36.622 M | |
| -121.55% | -644.06% | 125.35% | -201.37% | 61.73% | 62.28% | -21.60% | |||
| Income tax | -1.455 M | 975.000 K | -592.000 K | -131.000 K | 4.790 M | 8.149 M | 14.770 M | 8.909 M | |
| Net income basic | -5.191 M | 457.000 K | -7.199 M | -17.426 M | 13.007 M | 20.634 M | 31.940 M | 27.713 M | |
| 108.80% | -1,675.27% | -142.06% | 174.64% | 58.64% | 54.79% | -13.23% | |||
| Net income | -5.191 M | 457.000 K | -7.199 M | -17.426 M | 13.007 M | 20.634 M | 31.940 M | 27.713 M | |
| 108.80% | -1,675.27% | -142.06% | 174.64% | 58.64% | 54.79% | -13.23% |